Pigeon Corporation (FRA:9N3)

Intra-Cellular Therapies Revenue

Pigeon had revenue of 25.23B JPY in the quarter ending March 31, 2025, with 6.22% growth. This brings the company's revenue in the last twelve months to 105.65B, up 11.68% year-over-year. In the year 2024, Pigeon had annual revenue of 104.17B with 10.28% growth.

• Revenue (ttm): 105.65B JPY
• Revenue Growth: +11.68%
• P/S Ratio: 1.81
• Revenue / Employee: 34.46M JPY
• Employees: 3,066
• Market Cap: 1.18B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	104.17B	9.71B	10.28%
Dec 31, 2023	94.46B	-460.00M	-0.48%
Dec 31, 2022	94.92B	1.84B	1.98%
Dec 31, 2021	93.08B	-6.30B	-6.34%
Dec 31, 2020	99.38B	-9.09B	-8.38%